Warning: The NCBI web site requires JavaScript to function. more...
Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.
Arthritis Res Ther. 2008;10(6):R130. Epub 2008 Nov 7.
Related citations
Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.
Arthritis Rheum. 2008 Mar;58(3):754-63.
Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis.
Matsumoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.
Arthritis Res Ther. 2008;10(3):R66. Epub 2008 Jun 5.
Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.
Bruns L, Frey O, Morawietz L, Landgraf C, Volkmer R, Kamradt T.
Arthritis Res Ther. 2009;11(4):R117. Epub 2009 Jul 29.
B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis.
Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T.
Clin Exp Immunol. 2009 Feb;155(2):285-94. Epub 2008 Nov 20.
Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan.
Hanyecz A, Bárdos T, Berlo SE, Buzás E, Nesterovitch AB, Mikecz K, Glant TT.
Arthritis Rheum. 2003 Oct;48(10):2959-73.
T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA, Ye XJ, Myers LK, Brand DD, Rosloniec EF, Kang AH.
J Immunol. 2004 Aug 1;173(3):1795-801.
Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS, Bäcklund J, Vestberg M, Holmdahl R.
Arthritis Res Ther. 2004;6(6):R544-50. Epub 2004 Sep 23.
Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope.
Staines NA, Harper N, Ward FJ, Malmström V, Holmdahl R, Bansal S.
Clin Exp Immunol. 1996 Mar;103(3):368-75.
Delineation of five thyroglobulin T cell epitopes with pathogenic potential in experimental autoimmune thyroiditis.
Verginis P, Stanford MM, Carayanniotis G.
J Immunol. 2002 Nov 1;169(9):5332-7.
Differential recognition of altered peptide ligands distinguishes two functionally discordant (arthritogenic and nonarthritogenic) autoreactive T cell hybridoma clones.
Buzás EI, Hanyecz A, Murad Y, Hudecz F, Rajnavölgyi E, Mikecz K, Glant TT.
J Immunol. 2003 Sep 15;171(6):3025-33.
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, Tanaka Y, Minami R, Hayashi T, Goto D, Ito S, Nishimura Y, Sumida T.
Arthritis Res Ther. 2009;11(6):R167. Epub 2009 Nov 9.
Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
Clin Immunol. 2007 Jan;122(1):75-84. Epub 2006 Oct 11.
Mapping of V beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis.
Yanagisawa S, Koike M, Kariyone A, Nagai S, Takatsu K.
Int Immunol. 1997 Feb;9(2):227-37.
Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R, Wagar D, Stephens TA, Lee-Chan E, Singh B.
J Immunol. 2005 May 1;174(9):5306-15.
Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH.
J Immunol. 1998 Oct 1;161(7):3589-95.
Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis.
Mandik-Nayak L, Allen PM.
Immunol Res. 2005;32(1-3):5-13. Review.
T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
Suh CH, Freed JH, Cohen PL.
J Immunol. 2003 Feb 15;170(4):2229-35.
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
Arthritis Rheum. 2006 Aug;54(8):2423-33.
Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
Prakken BJ, Roord S, van Kooten PJ, Wagenaar JP, van Eden W, Albani S, Wauben MH.
Arthritis Rheum. 2002 Jul;46(7):1937-46.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on